Bluebird Bio Inc (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 346,629 | 327,214 | 300,426 | 280,995 | 221,738 |
| Marketable Securities | 564,054 | 779,246 | 879,529 | 972,885 | 1,100,079 |
| Receivables | N/A | N/A | N/A | 21,473 | N/A |
| Other current assets | 16,575 | 12,826 | 13,145 | 0 | 19,449 |
| TOTAL | $967,467 | $1,152,174 | $1,220,032 | $1,300,780 | $1,365,032 |
| Non-Current Assets | |||||
| PPE Net | 153,920 | 151,176 | 144,097 | 129,135 | 114,030 |
| Investments And Advances | 107,674 | 131,506 | 225,932 | 287,922 | 408,949 |
| Intangibles | 26,382 | 27,454 | 28,525 | 29,608 | 25,356 |
| Other Non-Current Assets | 273,661 | 265,114 | 273,632 | 275,899 | 225,248 |
| TOTAL | $561,637 | $575,250 | $672,186 | $722,564 | $773,583 |
| Total Assets | $1,529,104 | $1,727,424 | $1,892,218 | $2,023,344 | $2,138,615 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 30,527 | 42,995 | 41,874 | 29,458 | 30,241 |
| Accrued Expenses | 118,091 | 141,556 | 112,479 | 91,105 | 76,152 |
| Other current liabilities | 9,069 | 10,380 | 13,273 | 13,190 | 11,242 |
| TOTAL | $184,422 | $223,580 | $196,031 | $162,109 | $146,691 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,355 | 8,474 | 8,474 | 9,484 | 11,490 |
| Other Non-Current Liabilities | 214,458 | 209,060 | 212,567 | 211,122 | 205,048 |
| TOTAL | $224,249 | $218,851 | $224,477 | $224,861 | $219,825 |
| Total Liabilities | $408,671 | $442,431 | $420,508 | $386,970 | $366,516 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,783 | 2,781 | 2,767 | 2,763 | 2,756 |
| Common Shares | 556 | 554 | 553 | 553 | 551 |
| Retained earnings | -2,484,463 | -2,281,852 | -2,058,505 | -1,852,472 | -1,656,690 |
| Other shareholders' equity | -2,799 | -1,893 | -2,851 | -819 | -1,792 |
| TOTAL | $1,120,433 | $1,284,993 | $1,471,710 | $1,636,374 | $1,772,099 |
| Total Liabilities And Equity | $1,529,104 | $1,727,424 | $1,892,218 | $2,023,344 | $2,138,615 |